November 27, 2015
EU opens door for Impax’s Parkinson’s treating oral capsule Numient
Impax Laboratories has been granted by the European Commission (EC) authorization to market its Numient oral capsule formulation for the symptomatic treatment of adult patients with Parkinson’s disease.